Theravance Biopharma Enters Global Collaboration with Janssen for TD-1473 in Inflammatory Intestinal Diseases

February 7, 2018

Responsive image

DUBLIN, Feb. 7, 2018 /PRNewswire/ — Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) today announced that it has entered into a global co-development and commercialization agreement with Janssen Biotech, Inc., one of…

Category: Precious Metals